VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $209,650 | -42.0% | 48,530 | -11.4% | 0.13% | -40.7% |
| Q2 2023 | $361,165 | +25.0% | 54,805 | +28.8% | 0.21% | +34.6% |
| Q1 2023 | $288,847 | -6.5% | 42,540 | +1.8% | 0.16% | -1.2% |
| Q4 2022 | $308,821 | +25.5% | 41,789 | +67.6% | 0.16% | +64.3% |
| Q3 2022 | $246,000 | -8.2% | 24,934 | +1.5% | 0.10% | -1.0% |
| Q2 2022 | $268,000 | +1.5% | 24,569 | +5.3% | 0.10% | -16.1% |
| Q1 2022 | $264,000 | -27.9% | 23,335 | 0.0% | 0.12% | -14.5% |
| Q4 2021 | $366,000 | -9.9% | 23,335 | -1.5% | 0.14% | -22.9% |
| Q3 2021 | $406,000 | -27.0% | 23,693 | -8.4% | 0.18% | -21.8% |
| Q2 2021 | $556,000 | -22.8% | 25,870 | -46.0% | 0.23% | -24.7% |
| Q1 2021 | $720,000 | +17.6% | 47,914 | +2.8% | 0.30% | +19.7% |
| Q4 2020 | $612,000 | +15.7% | 46,602 | -14.9% | 0.25% | -8.3% |
| Q3 2020 | $529,000 | -7.8% | 54,777 | +9.2% | 0.28% | +1.8% |
| Q2 2020 | $574,000 | +57.7% | 50,163 | +42.6% | 0.27% | +81.3% |
| Q1 2020 | $364,000 | -41.9% | 35,168 | -7.8% | 0.15% | +47.1% |
| Q4 2019 | $626,000 | -0.6% | 38,136 | -19.7% | 0.10% | -19.7% |
| Q3 2019 | $630,000 | -19.3% | 47,470 | -14.4% | 0.13% | -23.0% |
| Q2 2019 | $781,000 | +31.9% | 55,444 | +144.7% | 0.16% | +63.4% |
| Q4 2018 | $592,000 | -39.7% | 22,661 | -47.0% | 0.10% | 0.0% |
| Q3 2018 | $982,000 | +29.2% | 42,777 | +7.2% | 0.10% | -85.0% |
| Q2 2018 | $760,000 | -29.6% | 39,895 | -37.7% | 0.67% | -28.2% |
| Q1 2018 | $1,079,000 | +4.7% | 64,040 | -5.6% | 0.94% | -27.7% |
| Q4 2017 | $1,031,000 | -22.9% | 67,813 | -9.3% | 1.29% | +618.9% |
| Q3 2017 | $1,338,000 | +9.9% | 74,733 | 0.0% | 0.18% | -1.1% |
| Q2 2017 | $1,218,000 | +34.4% | 74,733 | +15.5% | 0.18% | +13.0% |
| Q1 2017 | $906,000 | -2.9% | 64,713 | +10.6% | 0.16% | -42.3% |
| Q4 2016 | $933,000 | -2.5% | 58,490 | +1.7% | 0.28% | -39.7% |
| Q3 2016 | $957,000 | +70.0% | 57,536 | +14.4% | 0.46% | +10.8% |
| Q2 2016 | $563,000 | +0.5% | 50,287 | -25.0% | 0.42% | -45.9% |
| Q1 2016 | $560,000 | -10.3% | 67,021 | 0.0% | 0.77% | -54.9% |
| Q4 2015 | $624,000 | – | 67,021 | – | 1.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |